Ananda Developments - Phase 1 PK Study to be conducted on MRX1
RNS
Latest announcements
Announcement summary
Ananda Developments - Phase 1 PK Study to be conducted on MRX1
We're pleased to announce this crucial next step in our Phase 1 programme.
for more information on PK studies and why Australia has been selected as the jurisdiction of choice, please check out the latest two releases on the Updates tab here in the Hub.
Ask a question
Your question will be sent privately to Ananda Pharma. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Ananda Pharma a question about this announcement.